Companies: 10,795·Total market cap: $144.5T
Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZBOTCHealthcare
$0.70
$-0.00(-0.16%)
Market Cap$36587801
P/E Ratio
52W High$1.19
52W Low$0.252
Overview

Enzo Biochem, Inc. (ENZB) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · ENZB · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Enzo Biochem, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

ENZB insider buying and selling by quarter

ENZB insider selling · ENZB insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
1.1M551K0
2024 Q3
2024 Q4
2025 Q1
2025 Q3

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · ENZB ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

ENZB executive sell shares · ENZB board member insider trading · ENZB insider trading SEC filing

Showing 16 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Radoff Bradley Louis

Director

Other

Date

Aug 20

Shares

430,000

Price

$0.01

Value

$4K

View Form 4 on SEC.gov

PULLY STEVEN J

Director

Other

Date

Aug 20

Shares

239,992

Price

$0.01

Value

$2K

View Form 4 on SEC.gov

Eckert Patricia

CFO

Other

Date

Aug 20

Shares

28,328

Price

$0.01

Value

$283

View Form 4 on SEC.gov

COUCHMAN JONATHAN

Director

Other

Date

Aug 20

Shares

277,237

Price

$0.01

Value

$3K

View Form 4 on SEC.gov

Cannon Kara

CEO · Director

Other

Date

Aug 20

Shares

45,065

Price

$0.01

Value

$451

View Form 4 on SEC.gov

Radoff Bradley Louis

Director

Award

Date

Jan 16

Shares

142,897

Price

Value

View Form 4 on SEC.gov

PULLY STEVEN J

Director

Award

Date

Jan 16

Shares

142,897

Price

Value

View Form 4 on SEC.gov

COUCHMAN JONATHAN

Director

Award

Date

Jan 16

Shares

142,897

Price

Value

View Form 4 on SEC.gov

Cannon Kara

CEO · Director

Other

Date

Jul 24

Shares

70,885

Price

$1.17

Value

$83K

View Form 4 on SEC.gov

Cannon Kara

CEO · Director

Award

Date

Feb 23

Shares

150,000

Price

Value

View Form 4 on SEC.gov

Cannon Kara

CEO · Director

Option

Date

Feb 21

Shares

10,640

Price

Value

View Form 4 on SEC.gov

Cannon Kara

CEO · Director

Other

Date

Feb 21

Shares

5,823

Price

Value

View Form 4 on SEC.gov

PULLY STEVEN J

Director

Award

Date

Jan 31

Shares

79,365

Price

Value

View Form 4 on SEC.gov

TAGLIAFERRI MARY

Director

Award

Date

Jan 31

Shares

79,365

Price

Value

View Form 4 on SEC.gov

Radoff Bradley Louis

Director

Award

Date

Jan 31

Shares

79,365

Price

Value

View Form 4 on SEC.gov

PULLY STEVEN J

Director

Award

Date

Oct 30

Shares

17,730

Price

Value

View Form 4 on SEC.gov

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About ENZB insider trading

ENZB insider trades

Enzo Biochem, Inc. (ENZB) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Radoff Bradley Louis (Director), PULLY STEVEN J (Director), Eckert Patricia (CFO). Over the past 12 months, 5 insiders have filed transactions with the SEC. ENZB insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Enzo Biochem, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

ENZB insider trading · 5 questions

The insiders of Enzo Biochem, Inc. (ENZB) include executives and directors such as Radoff Bradley Louis (Director), PULLY STEVEN J (Director), Eckert Patricia (CFO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

ENZB board member insider tradingwho are ENZB insidersENZB insider rosterEnzo Biochem, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026